{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:13:43Z","timestamp":1790050423669,"version":"4.0.1"},"reference-count":30,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Scientific Research Projects (BAP) Coordination Unit of Izmir Katip \u00c7elebi University","award":["2022-GAP-TIPF-0021"],"award-info":[{"award-number":["2022-GAP-TIPF-0021"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms may influence folate metabolism and DNA synthesis, potentially affecting disease characteristics and clinical outcomes in hematologic malignancies. This study investigated the associations of MTHFR C677T and A1298C polymorphisms with clinical features and survival outcomes in adult patients with acute lymphoblastic leukemia (ALL) or non-Hodgkin lymphoma (NHL). Methods: A total of 92 adult patients with ALL or NHL treated with standard chemotherapy were retrospectively analyzed. MTHFR C677T and A1298C genotypes were determined using real-time polymerase chain reaction. Associations between genotypes and baseline clinical features, treatment response, toxicity, overall survival (OS), and progression-free survival (PFS) were examined. Results: The C677T heterozygous genotype was significantly associated with the presence of B symptoms (p = 0.027). No significant differences were observed across genotypes with respect to other baseline clinical features, treatment response, or treatment-related toxicity. In the overall cohort (ALL + NHL), OS and PFS did not differ significantly by C677T or A1298C genotypes. However, in the NHL cohort, carriers of the C677T variant demonstrated significantly shorter PFS (p = 0.048) and a non-significant trend toward lower OS. This association was also observed in the DLBCL subgroup for PFS (p = 0.043), with a similar non-significant trend observed for OS. Conclusions: Although MTHFR genotyping appears to have limited value for broad clinical stratification, the observed association between the C677T polymorphism and PFS in NHL\u2014particularly in the DLBCL subgroup\u2014suggests a potential subtype-specific relevance that warrants further validation in larger, disease-specific cohorts.<\/jats:p>","DOI":"10.3390\/jcm15051796","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:41:02Z","timestamp":1772188862000},"page":"1796","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Significance of MTHFR C677T and A1298C Polymorphisms in Adult Patients with ALL and NHL"],"prefix":"10.3390","volume":"15","author":[{"given":"Hatice Demet","family":"Kiper Unal","sequence":"first","affiliation":[{"name":"Department of Hematology, Izmir Katip Celebi University Ataturk Research and Training Hospital, 35730 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Cetintepe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Izmir Katip Celebi University Ataturk Research and Training Hospital, 35730 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6760-8921","authenticated-orcid":false,"given":"Roya","family":"Gasimli","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, Ege University, 35100 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alev","family":"Garip Acar","sequence":"additional","affiliation":[{"name":"Department of Hematology, Izmir Katip Celebi University Ataturk Research and Training Hospital, 35730 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemal","family":"Aygun","sequence":"additional","affiliation":[{"name":"Department of Hematology, Izmir Katip Celebi University Ataturk Research and Training Hospital, 35730 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serife","family":"Solmaz","sequence":"additional","affiliation":[{"name":"Department of Hematology, Izmir Katip Celebi University Ataturk Research and Training Hospital, 35730 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asli","family":"Subasioglu","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Izmir Katip Celebi University Ataturk Research and Training Hospital, 35730 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saliha","family":"Aksun","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Izmir Katip Celebi University Ataturk Research and Training Hospital, 35730 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7471-5453","authenticated-orcid":false,"given":"Bahriye","family":"Payzin","sequence":"additional","affiliation":[{"name":"Department of Hematology, Izmir Katip Celebi University Ataturk Research and Training Hospital, 35730 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41375-021-01189-2","article-title":"Folate metabolism: A re-emerging therapeutic target in haematological cancers","volume":"35","author":"Zarou","year":"2021","journal-title":"Leukemia"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.hoc.2012.02.002","article-title":"The antifolates","volume":"26","author":"Visentin","year":"2012","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ejca.2008.12.004","article-title":"C677T and A1298C MTHFR polymorphisms: A challenge for antifolate and fluoropyrimidine-based therapy personalization","volume":"45","author":"Toffoli","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00280-011-1751-4","article-title":"The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue","volume":"69","author":"Chiusolo","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_5","first-page":"1052","article-title":"Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype\/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency","volume":"56","author":"Goyette","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/mgme.1998.2714","article-title":"A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity","volume":"64","author":"Weisberg","year":"1998","journal-title":"Mol. Genet. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/aje\/kwp275","article-title":"Meta- and pooled analyses of the MTHFR C677T polymorphism and colorectal cancer: A HuGE-GSEC review","volume":"170","author":"Taioli","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.1038\/s41598-018-25726-9","article-title":"The association between MTHFR polymorphism and cervical cancer","volume":"8","author":"Gong","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1055-9965.EPI-06-0334","article-title":"5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: A meta-analysis","volume":"15","author":"Pereira","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1038\/srep06159","article-title":"Association of MTHFR C677T and A1298C polymorphisms and non-Hodgkin lymphoma susceptibility: Evidence from a meta-analysis","volume":"4","author":"He","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1158\/1055-9965.787.13.5","article-title":"Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin\u2019s lymphoma in adults","volume":"13","author":"Gemmati","year":"2004","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/0008-5472.CAN-04-2606","article-title":"Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia","volume":"65","author":"Aplenc","year":"2005","journal-title":"Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.leukres.2007.03.028","article-title":"MTHFR polymorphisms\u2019 influence on outcome and toxicity in acute lymphoblastic leukemia patients","volume":"31","author":"Chiusolo","year":"2007","journal-title":"Leuk Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/tpj.2012.44","article-title":"A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia","volume":"13","author":"Ballesteros","year":"2013","journal-title":"Pharmacogenomics J."},{"key":"ref_16","first-page":"2638","article-title":"Influence of methylenetetrahydrofolate reductase gene polymorphisms on the outcome of pediatric patients with non-Hodgkin lymphoma treated with high-dose methotrexate","volume":"54","author":"Ramaglia","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00277-006-0175-4","article-title":"Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy","volume":"85","author":"Timuragaoglu","year":"2006","journal-title":"Ann. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.7150\/jca.99351","article-title":"Association of MTHFR gene polymorphisms with non-Hodgkin lymphoma risk: Evidence from 31 articles","volume":"15","author":"Wang","year":"2024","journal-title":"J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.12659\/MSM.892835","article-title":"Association between MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: A meta-analysis based on 51 case-control studies","volume":"21","author":"Li","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3109\/10428194.2011.589545","article-title":"Methylenetetrahydrofolate reductase gene polymorphisms and acute lymphoblastic leukemia risk: A meta-analysis based on 28 case-control studies","volume":"52","author":"Tong","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wang, H., Wang, J., Zhao, L., Liu, X., and Mi, W. (2012). Methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia\u2014Evidence from an updated meta-analysis including 35 studies. BMC Med. Genet., 13.","DOI":"10.1186\/1471-2350-13-77"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/pbc.23137","article-title":"A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children","volume":"58","author":"Yan","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ajh.20215","article-title":"Methylenetetrahydrofolate reductase gene polymorphisms and risk of malignant lymphoma in a Japanese population","volume":"77","author":"Matsuo","year":"2004","journal-title":"Am. J. Hematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3109\/10428194.2011.563883","article-title":"Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population","volume":"52","author":"Liu","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10038-006-0096-z","article-title":"Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma","volume":"52","author":"Imanishi","year":"2007","journal-title":"J. Hum. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00277-005-0072-2","article-title":"MTHFR 677 (C\u2192T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: Results from 484 patients of multicenter trial NHL-BFM 95","volume":"85","author":"Seidemann","year":"2006","journal-title":"Ann. Hematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/10428190902893819","article-title":"Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma","volume":"50","author":"Kantar","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3324\/haematol.10587","article-title":"Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin\u2019s lymphoma patients: Association with toxicity and survival","volume":"92","author":"Gemmati","year":"2007","journal-title":"Haematologica"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1080\/10428194.2021.1927017","article-title":"Influence of MTHFR C677T and A1298C polymorphisms on the survival of pediatric patients with non-Hodgkin lymphoma","volume":"62","author":"Zhu","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s13277-014-2946-1","article-title":"The methylenetetrahydrofolate reductase (MTHFR) 677 C>T polymorphism increases the risk of developing chronic myeloid leukemia\u2014A case-control study","volume":"36","author":"Iancu","year":"2015","journal-title":"Tumour Biol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/5\/1796\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:09:02Z","timestamp":1772190542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/5\/1796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15051796"],"URL":"https:\/\/doi.org\/10.3390\/jcm15051796","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}